Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP

Genes and Development

Volumn 24, Issue 21, 2010, Pages 2430-2439

  Vigneron, Arnaud M ^a   Ludwig, Robert L ^a   Vousden, Karen H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Apoptosis; ASPP1; LATS; YAP

Indexed keywords

APOPTOSIS STIMULATING PROTEIN OF P53; BIM PROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ANOIKIS; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANOIKIS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; HYDROXYUREA; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION;

EID: 78049450251     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1954310     Document Type: Article

References (42)

1. Agirre X, Roman-Gomez J, Jimenez-Velasco A, Garate L, Montiel-Duarte C, Navarro G, Vazquez I, Zalacain M, Calasanz MJ, Heiniger A, et al. 2006. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene 25: 1862-1870.
2. Ahn J, Byeon IJ, Byeon CH, Gronenborn AM. 2009. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins. J Biol Chem 284: 13812-13822.
3. Aylon Y, Michael D, Shmueli A, Yabuta N, Nojima H, Oren M. 2006. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev 20: 2687-2700. (Pubitemid 44498379)
4. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, Oren M. 2010. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev (this issue). doi: 10.1101/gad.1954410.
5. Bergamaschi D, Samuels-Lev Y, O'Neil NJ, Trigiante G, Crook T, Hseih JK, O'Conner DJ, Zhong S, Compargue I, Tomlinson ML, et al. 2003. iASPP oncoprotein is a key inhibitor of p53 conserved from worms to humans. Nat Genet 33: 162-167. (Pubitemid 36177067)
6. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X. 2004. ASPP1 and ASPP2: Common activators of p53 family members. Mol Cell Biol 24: 1341-1350. (Pubitemid 38112194)
7. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, et al. 2006. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133-1141. (Pubitemid 44470358)
8. Bertini E, Oka T, Sudol M, Strano S, Blandino G. 2009. YAP: At the crossroad between transformation and tumor suppression. Cell Cycle 8: 49-57.
9. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. 1998. Requirement for p53 and p21 to sustain G2arrest after DNA damage. Science 282: 1497-1501. (Pubitemid 28538613)
10. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, Hong W. 2008. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598.
11. Cong W, Hirose T, Harita Y, Yamashita A, Mizuno K, Hirano H, Ohno S. 2010. ASPP2 regulates epithelial cell polarity through the PAR complex. Curr Biol 20: 1408-1414.
12. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D. 2007. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133. (Pubitemid 47410268)
13. Espanel X, Sudol M. 2001. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem 276: 14514-14523. (Pubitemid 37391846)
14. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. 2008. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496-5509.
15. Hergovich A, Hemmings BA. 2009. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. Biofactors 35: 338-345.
16. Hirashima M, Sano K, Morisada T, Murakami K, Rossant J, Suda T. 2008. Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. Dev Biol 316: 149-159.
17. Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S. 1994. Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci 91: 6098-6102. (Pubitemid 24188290)
18. Kampa KM, Acoba JD, Chen D, Gay J, Lee H, Beemer K, Padiernos E, Boonmark N, Zhu Z, Fan AC, et al. 2009a. Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds. Proc Natl Acad Sci 106: 4390-4395.
19. Kampa KM, Bonin M, Lopez CD. 2009b. New insights into the expanding complexity of the tumor suppressor ASPP2. Cell Cycle 8: 2871-2876.
20. Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, et al. 2000. TAZ: A novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19: 6778-6791.
21. Langton PF, Colombani J, Aerne BL, Tapon N. 2007. Drosophila ASPP regulates C-terminal Src kinase activity. Dev Cell 13: 773-782. (Pubitemid 350163042)
22. Langton PF, Colombani J, Chan EH, Wepf A, Gstaiger M, Tapon N. 2009. The dASPP-dRASSF8 complex regulates cell-cell adhesion during Drosophila retinal morphogenesis. Curr Biol 19: 1969-1978.
23. Mantovani F, Tocco F, Girardini J, Smith P, Gasco M, Lu X, Crook T, Del Sal G. 2007. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol 14: 912-920. (Pubitemid 47525182)
24. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D, Baccarini M, Vass JK, Kolch W, O'Neill E. 2007. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962-975.
25. Oka T, Mazack V, Sudol M. 2008. Mst2 and Lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP). J Biol Chem 283: 27534-27546.
26. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA. 2006. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci 103: 12405-12410.
27. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Prosper F, Heiniger A, Torres A. 2005. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis. J Clin Oncol 23: 7043-7049.
28. Samuels-Lev Y, O'Conner DJ, Bergamaschi D, Trigiante G, Hsieh J-K, Zhong S, Campargue I, Naumovski L, Crook T, Lu X. 2001. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8: 781-794. (Pubitemid 33030212)
29. Sottocornola R, Royer C, Vives V, Tordella L, Zhong S, Wang Y, Ratnayaka I, Shipman M, Cheung A, Gaston-Massuet C, et al. 2010. ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development. Dev Cell 19: 126-137.
30. Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, Mantovani F, Damalas A, Citro G, Sacchi A, et al. 2005. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol Cell 18: 447-459.
31. Sullivan A, Lu X. 2007. ASPP: A new family of oncogenes and tumour suppressor genes. Br J Cancer 96: 196-200. (Pubitemid 46160620)
32. Thornton JK, Dalgleish C, Venables JP, Sergeant KA, Ehrmann IE, Lu X, Saunders PT, Elliott DJ. 2006. The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo. Oncogene 25: 3104-3112.
33. Trigiante G, Lu X. 2006. ASPP and cancer. Nat Rev Cancer 6: 217-226.
34. Vives V, Su J, Zhong S, Ratnayaka I, Slee E, Goldin R, Lu X. 2006. ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes Dev 20: 1262-1267.
35. Wang K, Degerny C, Xu M, Yang XJ. 2009. YAP, TAZ, and Yorkie: A conserved family of signal-responsive transcriptional coregulators in animal development and human disease. Biochem Cell Biol 87: 77-91.
36. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, et al. 2006. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267.
37. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, et al. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761. (Pubitemid 350070721)
38. Zhao B, Lei QY, Guan KL. 2008a. The Hippo-YAP pathway: New connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646.
39. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, et al. 2008b. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971. (Pubitemid 352008643)
40. Zhao B, Li L, Lei Q, Guan KL. 2010a. The Hippo-YAP pathway in organ size control and tumorigenesis: An updated version. Genes Dev 24: 862-874.
41. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. 2010b. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(b-TRCP). Genes Dev 24: 72-85.
42. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y. 2010. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 51: 142-153.